Tracking SPRY historical volatility helps you see how much ARS Pharmaceuticals Inc's stock price has actually moved over past periods, giving you a baseline to judge whether current option premiums are fair, cheap, or expensive. While implied volatility tells you what the market expects, ARS Pharmaceuticals Inc's HV tells you what really happened. Use our scanner to monitor SPRY 30 day historical volatility alongside longer lookback windows and spot the moments when realized and implied diverge.
Historical volatility is the annualized standard deviation of an underlying's past returns, typically measured over rolling windows like 10, 20, 30, or 60 days. The SPRY 30 day historical volatility is one of the most widely watched readings because it balances responsiveness with stability. Comparing ARS Pharmaceuticals Inc's HV to its implied volatility reveals the volatility risk premium — when IV sits well above HV, option sellers tend to have an edge; when HV runs hot relative to IV, buyers may be underpaying for movement.
ARS Pharmaceuticals, Inc. develops ARS-1, a novel intranasal epinephrine spray with absorption technology for patients and their families at-risk of severe allergic reactions to food, medications, and insect bites. Its product includes Neffy, a low-dose intranasal epinephrine nasal spray. The company was incorporated in 2015 and is based in San Diego, California.
Sizing a long premium trade, modeling a covered call, or hunting volatility arbitrage all come back to one question: how much has the stock actually moved? Our scanner puts ARS Pharmaceuticals Inc's historical volatility side-by-side with implied readings across every lookback window, so you can see exactly where SPRY HV is running hot, cold, or in line. Make the SPRY 30 day historical volatility — and every other window — work for your edge instead of against it.
